Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Aug. 3, 2015 HBIO A 11,247 · · 21,582 Direct +108.82% Acquired (price as of 2026-10-06)
June 4, 2015 HBIO A 19,500 · · 19,500 Direct · Acquired (price as of 2026-10-06)
June 4, 2015 HBIO A 10,335 · · 10,335 Direct · Acquired (price as of 2026-10-06)
May 30, 2014 HBIO A 35,000 · · 35,000 Direct · Acquired (price as of 2026-10-06)
Nov. 18, 2013 HBIO A 50,000 · · 50,000 Direct · Acquired (price as of 2026-10-06)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
June 4, 2015 HBIO Stock option (right to buy) Common Stock, par value $0.01 per share (19,500) $5.56 June 4, 2025 19,500 Acquired
May 30, 2014 HBIO Stock option (right to buy) Common Stock, par value $0.01 per share (35,000) $4.12 May 30, 2024 35,000 Acquired
Nov. 18, 2013 HBIO Stock option (right to buy) Common Stock, par value $0.01 per share (50,000) $4.31 Nov. 18, 2023 50,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2015 $165,500 · · $40,950 · · $13,452 $331,463
2014 $185,500 $25,000 · · · · · $304,134
2013 $34,041 · · $111,185 · · · $145,226

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.